Pharmaceutical research is under pressure to bridge discovery and market access more efficiently. PharmaNEXT 2027 convenes academic groups and industry actors for two days in Barcelona with a hybrid format to present methods and results relevant to drug R&D.
Dates and hybrid format for PharmaNEXT 2027
PharmaNEXT 2027 runs June 24 to 25, 2027 in Barcelona and accepts both in-person attendance and virtual participation via Zoom. Important deadlines include abstract submission by September 30, 2026 and an Early Bird registration closing on October 15, 2026.
Registration categories include in-person delegates, virtual delegates and rates for young researchers or poster presenters. The virtual track enables international teams to join sessions without travel.
Program focus and scientific tracks
The conference program spans the drug development lifecycle. Explicit tracks include drug discovery, pharmacokinetics and pharmacodynamics, advanced formulations, next generation drug delivery, biopharmaceuticals and pharmacogenomics. AI and machine learning applications in drug design and combined PBPK PD modeling are also listed among session topics.
Organizers indicate presentations by more than 50 international experts and a mix of interactive scientific sessions, applied case studies and regulatory insights. The structure allows attendees to target content relevant to laboratory workflows, clinical evaluation and safety assessment.
Attendee and exhibitor profile
PharmaNEXT 2027 targets scientists, researchers and industry professionals in pharmaceutical and biotech sectors. Expected profiles include pharmacologists, toxicologists, clinical researchers, formulation scientists and industry leaders focused on product development.
Exhibition space features companies offering analytical platforms, formulation technologies, manufacturing solutions and delivery systems. The hybrid configuration permits exhibitors to combine on-site demos with digital collateral for virtual delegates.
Preparing B2B outreach at the conference
Map target contacts by technical need and development stage. Use technical sessions to detect projects that may require formulation partners, PKPD modeling or delivery technologies. Schedule concise meetings and ensure digital assets are ready for remote attendees.
If submitting an abstract, align content with the listed scientific sessions and respect the submission deadline. Commercial teams should frame value propositions around regulatory compatibility and proven technical capabilities.
Closing note and official link
PharmaNEXT 2027 concentrates practical content on tools and processes that carry a compound from discovery to clinical evaluation and market. For registration details, program breakdown and abstract submission consult https://www.pharmanext.org/
